Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
International Journal of Clinical Oncology|January 14, 2012
Initial report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japanese patientsYasunori Emi, Yoshihiro Kakeji, Eiji Oki, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 27, 2009
MR prediction of postnatal outcomes in left-sided congenital diaphragmatic hernia using right lung signal intensity: comparison with that using right lung volumeAkihiro Nishie, Tsuyoshi Tajima, Yoshiki Asayama, et al.
Annals of Surgical Oncology|October 7, 2022
A Prospective Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial InvolvementNaoki Ikenaga, Yoshihiro Miyasaka, Takao Ohtsuka, et al.
Anticancer Research|November 5, 2014
Liver resectability of advanced liver-limited colorectal liver metastases following mFOLFOX6 with bevacizumab (KSCC0802 Study)Toru Beppu, Yasunori Emi, Shoji Tokunaga, et al.
Medicine|March 10, 2023
Transcatheter arterial steroid injection therapy improves the prognosis of patients with acute liver failureAkifumi Kuwano, Tasuku Okui, Motoyuki Kohjima, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 30, 2025
Establishment of simple pancreatic ductal adenocarcinoma identification method: S100P measurement in duodenal fluid obtained during upper gastrointestinal endoscopyNoboru Ideno, Keiji Hanada, Shoji Tokunaga, et al.
International Journal of Clinical Oncology|June 9, 2026
Volume-adjusted p2PSA-derived indices for predicting prostate cancer: the PROPHET studyMasaki Shiota, Yoshitaka Sekine, Shoji Tokunaga, et al.
EJNMMI Research|June 2, 2026
GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancerTokiyoshi Tanegashima, Masaki Shiota, Atsushi Doi, et al.
The Journal of Urology|August 21, 2019
Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/mlKazuto Ito, Akira Yokomizo, Shoji Tokunaga, et al.
Surgery Today|December 31, 2010
A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as second-line treatment for advanced colorectal cancer: a Japanese experienceYutaka Ogata, Shoji Tokunaga, Yasunori Emi, et al.
Pageof 12